Health care professionals can have a powerful impact on labeling requirements for drugs by formally petitioning the FDA for ...

Long-term Phase 1/2a and open label extension (OLE) data for zorevunersen on top of standard of care anti-seizure medicines (ASMs)demonstrate ...

Women with polycystic ovary syndrome are increasingly turning to blockbuster weight-loss drugs from Eli Lilly and Novo ...

Women with polycystic ovary syndrome are increasingly turning to blockbuster weight-loss drugs from Eli Lilly and Novo ...

—Long-term Phase 1/2a and open label extension (OLE) data for zorevunersen on top of standard of care anti-seizure medicines (ASMs) demonstrate durable seizure reductions, including increases in ...

Developed the world's first multimodal brain signal-based model capable of learning without simultaneous EEG and fNIRS measurements. - Self-learning from data of hundreds of individuals... Introducing ...

Clear recognition of high unmet need and urgency for the SCN2A community and plausibility of the mechanism of elsunersen FDA agreed to proposed ...

Post-hoc analysis of RAP-219 Phase 2a data showed early onset of action and consistency of median response over the entire ...

This article was reviewed by Sara Harcharik Perkins, MD. Spironolactone for Hair Loss: Benefits, Dosage, and Risks Key ...

The Food and Drug Administration (FDA) has approved updated labeling for Unloxcyt™ (cosibelimab-ipdl) for the treatment of adults with metastatic ...

BeOne Medicines AG is rated Strong Buy as Brukinsa and Tevimbra drive robust growth and pipeline catalysts approach. Learn ...

London, UK, Boston, MA, 9 November 2025 – George Medicines, a late-stage biopharmaceutical company focused on addressing significant unmet needs in cardiometabolic disease, today presented long-term ...